14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:GNCA
Delisted

Genocea Biosciences Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0001
+0 (+0%)
At Close: Apr 19, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0001 $0.0001 Wednesday, 19th Apr 2023 GNCA stock ended at $0.0001. During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001.
90 days $0.0001 $0.0001
52 weeks $0.0001 $0.469

Historical Genocea Biosciences prices

Date Open High Low Close Volume
Nov 22, 2022 $0.0009 $0.0100 $0.0009 $0.0100 8 504
Nov 21, 2022 $0.0007 $0.0100 $0.0007 $0.0100 60 925
Nov 18, 2022 $0.0007 $0.0100 $0.0007 $0.0100 213 129
Nov 17, 2022 $0.0007 $0.0064 $0.0007 $0.0064 16 877
Nov 16, 2022 $0.0007 $0.0007 $0.0007 $0.0007 11 889
Nov 15, 2022 $0.0007 $0.0060 $0.0007 $0.0007 216 026
Nov 14, 2022 $0.0007 $0.0059 $0.0007 $0.0059 2 170
Nov 11, 2022 $0.0007 $0.0008 $0.0007 $0.0007 32 097
Nov 10, 2022 $0.0007 $0.0059 $0.0007 $0.0007 30 235
Nov 09, 2022 $0.0007 $0.0008 $0.0007 $0.0007 25 078
Nov 08, 2022 $0.0013 $0.0013 $0.0013 $0.0013 37 581
Nov 07, 2022 $0.0007 $0.0050 $0.0007 $0.0015 58 842
Nov 04, 2022 $0.0059 $0.0059 $0.0059 $0.0059 0
Nov 03, 2022 $0.0006 $0.0059 $0.0006 $0.0059 123 347
Nov 02, 2022 $0.0006 $0.0058 $0.0006 $0.0058 2 310
Nov 01, 2022 $0.0058 $0.0058 $0.0058 $0.0058 301
Oct 31, 2022 $0.0058 $0.0058 $0.0058 $0.0058 0
Oct 28, 2022 $0.0005 $0.0058 $0.0005 $0.0058 51 088
Oct 27, 2022 $0.0005 $0.0059 $0.0005 $0.0059 10 500
Oct 26, 2022 $0.0005 $0.0059 $0.0005 $0.0059 11 127
Oct 25, 2022 $0.0015 $0.0059 $0.0005 $0.0059 12 189
Oct 24, 2022 $0.0059 $0.0059 $0.0059 $0.0059 10 010
Oct 21, 2022 $0.0059 $0.0059 $0.0059 $0.0059 0
Oct 20, 2022 $0.0014 $0.0059 $0.0014 $0.0059 12 203
Oct 19, 2022 $0.0005 $0.0065 $0.0005 $0.0065 11 250
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT